PhRMA Annual Meeting Archives

#PhRMA12Blogs from John Castellani and John Lechleiter

#PhRMA12 Highlights
Speakers and attendees share comments on the activity at #PhRMA12.
 
#PhRMA12 in Full
Proceedings from the 2011 Annual Meeting of the Pharmaceutical Research and Manufacturers of America.
 

#PhRMA12

Highlights from the 2012 Annual Meeting of the Pharmaceutical Research and Manufacturers of America.

Storified by PhRMA · Wed, May 09 2012 13:35:43

Same here! See you there. Safe travels. RT @eg292: Heading to Boston tomorrow for #PhRMA12...looking forward to hearing Malcolm GladwellStopAfib.org
PhRMA will live-stream its annual meeting today to engage audience through social media. Connect on Twitter w/ #PhRMA12 http://ow.ly/aeALWNJBIZ
The PhRMA Annual Meeting is now under way! Make sure to follow #PhRMA12 and watch our #livestream at http://bit.ly/HsAzA8 to keep up. #hcsmPhRMA
#PhRMA12 just getting started for the day. So many excitng things on the agenda today.StopAfib.org
New on Off Label: #PhRMA12 has heavy dose of social media http://bit.ly/HEFnzjJared Kaltwasser
#PhRMA12 chair, Chris Viebacher: Media & advocacy groups here this year, increasing transparency. Very important!StopAfib.org
Have seen more coverage from #PhRMA12 already via Tweets than the combined news coverage of last 5 PhRMA annual mtgs - well done!Josh Berlin
Sanofi CEO and PhRMA Chairman Christopher Viehbacher said rising costs of health care keep him up at night #PhRMA12 #pharmaSCRIP Intelligence
Viehbacher citing @matthewherper article on number of drugs approved in past 10 years vs R&D spend #PhRMA12 Need link t that...Sanofi US
@SanofiUS The Truly Staggering Cost Of Inventing New Drugs - Forbes http://onforb.es/yNffHTMatthew Herper
Spoke at @PhRMA this morning. The pharmaceutical industry is a critical piece of our innovation economy. http://www.mass.gov/governor/pressoffice/pressreleases/2012/2012412-gove... Patrick
Gov Patrick: Growth comes from investment - education, innovation and infrastructure #PhRMA12 #yamSanofi US
Mass Gov Deval Patrick: While it is popular to emphasize austerity, I emphasize investment #PhRMA12 #pharmaSCRIP Intelligence
Preferences matter - "Patients want to be engaged in their own care" says Sally Greenberg of Nat. Consumer League #PhRMA12Glen Giovannetti
"Identify and reward healthy behaviors in the workplace." to promote #prevention says Ron Williams, former Aetna CEO #PhRMA12Mike Capaldi
Nearly 30% of patients don't fill a new Rx. Nonadherence to meds can lead to poor health outcomes + cost up to $300B annually. #PhRMA12GlaxoSmithKline US
A bright spot in HC policy is the management of chronic disease and prevention. -Chris Jennings #PhRMA12Sanofi US
"My impression of the meeting so far: a bunch of very dedicated, passionate people telling our industry's story" -Ron G. #PhRMA12PhRMA Annual Meeting
Tough to write when all I want to do is read #TEDMED, #PhRMA12, & #RxSummit tweetsKristina Fiore
"Great to be in Boston with patient, business, labor and academic leaders from around the globe! " -Scott L. #PhRMA12PhRMA Annual Meeting
Malcolm Gladwell: Nobody ever wants to distinguish between a productive dollar and an unproductive dollar #PhRMA12 #pharma #biotechSCRIP Intelligence
"Malcolm Gladwell's inverted U will be keeping me looking at problem solving in a different way." -Holly T. #PhRMA12PhRMA Annual Meeting
About to start 1st of 2 back-2-back panels @ #PhRMA12. 1st on rare diseases w/Genzyme's Dr. David Meeker $SNY, 2nd on partnerships.Mike Huckman
“@GenzymeCorp: Today nearly 20 million Americans have one of about 7,000 #rarediseases #PhRMA12” I am one.Monique E Griffin
Rare diseases aren’t that rare. There are 7K of them, and 6-8% of the world population are affected. #PhRMA12GlaxoSmithKline US
#RareDisease drug development happens most effectively when done in partnership with patients and families. -Meeker #PhRMA12Genzyme Corporation
@GenzymeCorp I'm really liking what David Meeker is saying. He needs a Twitter account too!Monique E Griffin
3rd Rock's Borisy warned academics not to become too commercial. They need time to explore basic research #PhRMA12 #pharma #biopharmaSCRIP Intelligence
It's been awesome. RT @PhRMA12 "This conference excels at partnerships between industry and patient advocacy groups!" -Douglas F. #PhRMA12StopAfib.org
Reading Tweets from #PhRMA12 as I receive my Lumizyme infusion which was manufactured by @GenzymeCorp!Monique E Griffin
Awesome! Could be because there are patient grps here tweeting. RT @CCatPhRMA Patients top trending word at #PhRMA12 http://twitter.com/CCatPhRMA/status/190786291699429376/photo/1StopAfib.org
The focus on "what #patients want" here at the #PhRMA12 annual meeting has been impressive, and awesome! Thanks, PhRMA.StopAfib.org
Patient voice is critical. RT @PearlF: #PHRMA12 Lilly CEO: US can be a model for what patient advocacy can look likeLilly
Another PhRMA fact from Dow Jones:3200 trials underway vs 2400 in '05 - http://online.wsj.com/article/BT-CO-20120412-713608.htmlJohn Carroll
Bind CEO at #PhRMA12 - US comps are making a mistake if they think it's all about exporting to EMs. Big point - reverse innovation.Josh Berlin
Surprised Merck at #PhRMA12 hasn't yet mentioned the Hep B vaccine it essentially donated to China - that's had a huge impact.Josh Berlin
Lilly CEO & PhRMA Chairman John Lechleiter: Name a product that extends life. It ain't an iPad #PhRMA12 #pharma #biotech #biopharmaSCRIP Intelligence
A most important sound bite. RT @FasterCures RT @sanofiUSVOICES: "Partnerships can't be transactional" says @FasterCures panelist. #phrma12StopAfib.org
Well done, #PhRMA. Thanks much for inviting #patients to participate in #PhRMA12. Signing off now as flight has no wi-fi (bummer!)StopAfib.org

 

#PhRMA11Live blogs from Kate Connors and Grady Forrer

#PhRMA11 Highlights
Speakers and attendees share comments on the activity at #PhRMA11.
 
#PhRMA11 in Full
Proceedings from the 2011 Annual Meeting of the Pharmaceutical Research and Manufacturers of America.
 

Full #PhRMA11 Meeting Archive

#PhRMA10Remarks from David Brennan, Jeff Kindler and Billy Tauzin

#PhRMA10 in Full
Proceedings from the 2010 Annual Meeting of the Pharmaceutical Research and Manufacturers of America.
 

Full #PhRMA10 Meeting Archive